New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

Lower Manhattan-based Metsera is one of the latest drug startups to throw its hat into the ring with the pharma giants ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Has something changed regarding Eli Lilly or Regeneron's thesis, or is the recent dip an excellent opportunity to invest in ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

The drug - in the form of its Mounjaro KwikPen device - was approved by the UK's ... Back in June, the Society for Acute Medicine warned that doctors were treating "increasing numbers" of patients ...

Data for tirzepatide, the chemical compound Lilly sells as Mounjaro and Zepbound, has separately showed the blockbuster ...

That hasn’t been discussed enough, Sadiya Khan, MD (Northwestern University Feinberg School of Medicine, Chicago ... Novo ...